| Autor: |
Fábio A, Morais, Isabela S, Lemos, Rafaela T, Matiola, Maria Luísa S, Freitas, Carolina G, Alano, Julia, Cabral, Leticia B, Wessler, Jaqueline S, Generoso, Giselli, Scaini, Gislaine Z, Réus, Emilio L, Streck |
| Rok vydání: |
2021 |
| Předmět: |
|
| Zdroj: |
Metabolic brain disease. 37(5) |
| ISSN: |
1573-7365 |
| Popis: |
Maple Syrup Urine Disease (MSUD) is caused by the deficiency in the activity of the branched-chain α-ketoacid dehydrogenase complex (BCKDC), resulting in the accumulation of the branched-chain amino acids (BCAA) leucine, isoleucine, and valine, and their respective branched-chain α-keto acids. Patients with MSUD are at high risk of developing chronic neuropsychiatric disorders; however, the pathophysiology of brain damage in these patients remains unclear. We hypothesize that MSUD can cause depressive symptoms in patients. To test our hypothesis, Wistar rats were submitted to the BCAA and tianeptine (antidepressant) administration for 21 days, starting seven days postnatal. Depression-like symptoms were assessed by testing for anhedonia and forced swimming after treatments. After the last test, the brain structures were dissected for the evaluation of neutrophins. We demonstrate that chronic BCAA administration induced depressive-like behavior, increased BDNF levels, and decreased NGF levels, suggesting a relationship between BCAA toxicity and brain damage, as observed in patients with MSUD. However, the administration of tianeptine was effective in preventing behavioral changes and restoring neurotrophins levels. |
| Databáze: |
OpenAIRE |
| Externí odkaz: |
|
Full text from SpringerLink